MCT1 inhibition by a single dose of AZD3965 (ranging from 1 nmol/L to 10 μmol/L) at time 0 did not significantly influence cancer cell survival and did not significantly accelerate cell death (Figure 3A and Table 1). The gene discussed is SLC16A1; the disease is cancer.